Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Boehringer Ingelheim
Merck
Express Scripts
Harvard Business School

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tesetaxel

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Tesetaxel: Sponsors, patents, clinical trial progress

Tesetaxel is an investigational drug.

There have been 15 clinical trials for Tesetaxel. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.

The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Melanoma. The leading clinical trial sponsors are Genta Incorporated, Odonate Therapeutics, Inc., and Odonate Therapeutics, LLC.

There are seven US patents protecting this investigational drug and sixty-nine international patents.

Recent Clinical Trials for Tesetaxel
TitleSponsorPhase
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBCOdonate Therapeutics, Inc.Phase 2
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCOdonate Therapeutics, Inc.Phase 2
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA)Odonate Therapeutics, LLCPhase 3

See all Tesetaxel clinical trials

Clinical Trial Summary for Tesetaxel

Top disease conditions for Tesetaxel
Top clinical trial sponsors for Tesetaxel

See all Tesetaxel clinical trials

US Patents for Tesetaxel

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tesetaxel   Start Trial Method for producing 2-azetidinone derivative Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP)   Start Trial
Tesetaxel   Start Trial Crystals of taxane derivative and process for their production Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP)   Start Trial
Tesetaxel   Start Trial Method for producing pentacyclic taxans Daiichi Pharmaceutical Co., Ltd. (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
Colorcon
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.